Clifford Chance
India tightens norms for pharma M&A
10 November 2011
On 8 November 2011, the Indian government amended its foreign investment rules imposing a requirement to seek its approval for foreign direct investment ("FDI") in existing Indian pharmaceutical companies. FDI in greenfield pharmaceutical ventures can be made without the requirement of any such approval.
